Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OX40L blockade cellular nanovesicles for autoimmune diseases therapy

Journal article

Fu Y. et al, (2021), Journal of Controlled Release, 337, 557 - 570

Improved melanoma suppression with target-delivered TRAIL and Paclitaxel by a multifunctional nanocarrier

Journal article

Huang S. et al, (2020), Journal of Controlled Release, 325, 10 - 24

A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy

Journal article

Wang L. et al, (2018), Nanoscale, 10, 13673 - 13683

Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease

Journal article

Qu M. et al, (2018), Journal of controlled release, 287, 156 - 166

Erythrocyte‐membrane‐camouflaged nanoplatform for intravenous glucose‐responsive insulin delivery

Journal article

Fu Y. et al, (2018), Advanced Functional Materials, 28